9/21/2020 Real-world costs of azacitidine treatment in patients with higher-risk myelodysplastic syndromes/low blast-count acute myeloid leukemia Mozessohn L, Cheung MC, Mittmann N, Earle CC, Liu N, Buckstein R. JCO Oncol Pract. 2021; 17(4):e517-25. Epub 2020 Sep 21. DOI: https://doi.org/10.1200/op.20.00446
4/23/2020 Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada Bankar A, Zhao H, Iqbal J, Coxford R, Cheung MC, Mozessohn L, Earle CC, Gupta V. Leuk Lymphoma. 2020; 61(8):1908-19. Epub 2020 Apr 23. DOI: https://doi.org/10.1080/10428194.2020.1749607
4/17/2020 Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects Smyth L, Blunt DN, Gatov E, Nagamuthu C, Croxford R, Mozessohn L, Cheung MC. Br J Haematol. 2020; 191(3):396-404. Epub 2020 Apr 17. DOI: https://doi.org/10.1111/bjh.16635